Matt Brazier's Investment Diary

Matt Brazier's Investment Diary

Share this post

Matt Brazier's Investment Diary
Matt Brazier's Investment Diary
MaxCyte (NASDAQ:MXCT, LON:MXCT): unsexy genes
Copy link
Facebook
Email
Notes
More

MaxCyte (NASDAQ:MXCT, LON:MXCT): unsexy genes

Matt Brazier
May 31
6

Share this post

Matt Brazier's Investment Diary
Matt Brazier's Investment Diary
MaxCyte (NASDAQ:MXCT, LON:MXCT): unsexy genes
Copy link
Facebook
Email
Notes
More
1

An unloved stock and non-viral substitution competitor to Oxford BioMedica (LON:OXB) in the ex-vivo CGT market

Read →
Comments
User's avatar
© 2025 Matt Brazier
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More